Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia

Rift Valley fever phlebovirus (RVFV) is a highly pathogenic mosquito-borne virus with bioweapon potential due to its ability to be spread by aerosol transmission. Neurological symptoms are among the worst outcomes of infection, and understanding of pathogenesis mechanisms within the brain is limited...

Full description

Bibliographic Details
Main Authors: Margarita V. Rangel, Feliza A. Bourguet, Carolyn I. Hall, Dina R. Weilhammer
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/13/2/159
_version_ 1797297277220421632
author Margarita V. Rangel
Feliza A. Bourguet
Carolyn I. Hall
Dina R. Weilhammer
author_facet Margarita V. Rangel
Feliza A. Bourguet
Carolyn I. Hall
Dina R. Weilhammer
author_sort Margarita V. Rangel
collection DOAJ
description Rift Valley fever phlebovirus (RVFV) is a highly pathogenic mosquito-borne virus with bioweapon potential due to its ability to be spread by aerosol transmission. Neurological symptoms are among the worst outcomes of infection, and understanding of pathogenesis mechanisms within the brain is limited. RVFV is classified as an overlap select agent by the CDC and USDA; therefore, experiments involving fully virulent strains of virus are tightly regulated. Here, we present two methods for inactivation of live virus within samples derived from mouse microglia cells using commercially available kits for the preparation of cells for flow cytometry and RNA extraction. Using the flow cytometry protocol, we demonstrate key differences in the response of primary murine microglia to infection with fully virulent versus attenuated RVFV.
first_indexed 2024-03-07T22:18:45Z
format Article
id doaj.art-7c0cc1914e4a4a328b09facf2606df42
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-07T22:18:45Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-7c0cc1914e4a4a328b09facf2606df422024-02-23T15:30:23ZengMDPI AGPathogens2076-08172024-02-0113215910.3390/pathogens13020159Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse MicrogliaMargarita V. Rangel0Feliza A. Bourguet1Carolyn I. Hall2Dina R. Weilhammer3Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USABiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USAEnvironment, Safety & Health, Biosafety & Biogovernance Functional Area, Lawrence Livermore National Laboratory, Livermore, CA 94550, USABiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USARift Valley fever phlebovirus (RVFV) is a highly pathogenic mosquito-borne virus with bioweapon potential due to its ability to be spread by aerosol transmission. Neurological symptoms are among the worst outcomes of infection, and understanding of pathogenesis mechanisms within the brain is limited. RVFV is classified as an overlap select agent by the CDC and USDA; therefore, experiments involving fully virulent strains of virus are tightly regulated. Here, we present two methods for inactivation of live virus within samples derived from mouse microglia cells using commercially available kits for the preparation of cells for flow cytometry and RNA extraction. Using the flow cytometry protocol, we demonstrate key differences in the response of primary murine microglia to infection with fully virulent versus attenuated RVFV.https://www.mdpi.com/2076-0817/13/2/159Rift Valley fever phlebovirusinactivationselect agentparaformaldehydeguanidine hydrochloridemicroglia
spellingShingle Margarita V. Rangel
Feliza A. Bourguet
Carolyn I. Hall
Dina R. Weilhammer
Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia
Pathogens
Rift Valley fever phlebovirus
inactivation
select agent
paraformaldehyde
guanidine hydrochloride
microglia
title Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia
title_full Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia
title_fullStr Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia
title_full_unstemmed Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia
title_short Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia
title_sort evaluation of inactivation methods for rift valley fever virus in mouse microglia
topic Rift Valley fever phlebovirus
inactivation
select agent
paraformaldehyde
guanidine hydrochloride
microglia
url https://www.mdpi.com/2076-0817/13/2/159
work_keys_str_mv AT margaritavrangel evaluationofinactivationmethodsforriftvalleyfevervirusinmousemicroglia
AT felizaabourguet evaluationofinactivationmethodsforriftvalleyfevervirusinmousemicroglia
AT carolynihall evaluationofinactivationmethodsforriftvalleyfevervirusinmousemicroglia
AT dinarweilhammer evaluationofinactivationmethodsforriftvalleyfevervirusinmousemicroglia